James DArecca
CIK 1583903 · EVP, Chief Financial Officer · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.05M
Companies
6
Total Filings
41
Lifetime Open-Market Net
-$81.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HAE | EVP, Chief Financial Officer | 54,444 | $78.20 | $4.26M | $0 | 13 | 2026-05-19 |
| PBH | Director | 6,591 | $47.82 | $315.2K | $0 | 3 | 2025-08-06 |
| TXMD | Chief Financial Officer | 217,167 | $2.20 | $477.8K | -$81.2K | 4 | 2021-08-12 |
| Allergan plc (AGN) Delisted | SVP Chief Accounting Officer | 0 | — | — | $0 | 12 | 2020-05-11 |
| Allergan plc (AGNpA) Delisted | CHIEF ACCOUNTING OFFICER | 4,222 | — | — | $0 | 6 | 2018-01-02 |
| Allergan plc (ACTpA) Delisted | CHIEF ACCOUNTING OFFICER | 1,182 | — | — | $0 | 2 | 2015-03-09 |
Recent Filings · Page 5 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-07-03 | — | Grant (A) | — | $0 |
Showing 41–41 of 41
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.